Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR. While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own.
I have my family coming into town for my birthday, so naturally I am digging through my beauty and skincare stash to see what can get passed along to my mom while she’s here in a few days. It struck me the sheer volume of skincare I have and for every skin issue- redness, dryness, acne, anti-aging, etc. Every skincare need is represented in one way or another in my collection because my skin is so finicky!
One thing I’m lucky to have never dealt with is rosacea. Rosacea is a treatable, chronic inflammatory skin condition. I don’t have any personal experience with it, but it’s common enough that it affects an estimated 16 million Americans! I was so surprised to read that Mirvaso (brimonidine) topical gel, 0.33% is the first and only FDA- approved treatment developed to treat the persistent facial redness that comes with rosacea. I know I’ve seen other products that claim to help in infomercials, but Mirvaso is the real deal!
I love playing with makeup, but using proper skincare is more important by far. If you have issues with rosacea I would encourage you to try Mirvaso rather than trying to cover it with makeup! Mirvaso is said to work fast, providing same-day results that last up to 12 hours before the redness returns. They are currently hosting a sweepstakes to raise awareness of the treatment, encouraging people to Break Up With Your Makeup. You can check out more information and enter to win a trip to the Emmys in Los Angeles here.
If you are someone who suffers from rosacea, have you heard of Mirvaso? I hope if you have stumbled upon this post in looking for a treatment, that the information found here helps you!
Important Safety Information:
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/